Corbus Pharmaceuticals Holdings Inc. [NASDAQ: CRBP] surged by $0.24 during the normal trading session on Wednesday and reaching a high of $8.095 during the day while it closed the day at $7.82. Corbus Pharmaceuticals Holdings Inc. stock has also gained 6.98% of its value over the past 7 days. However, CRBP stock has inclined by 87.53% in the 3 months of the year. Over the past six months meanwhile, it has gained 51.84% and gained 43.22% year-on date.
The market cap for CRBP stock reached $549.67 million, with 69.27 million shares outstanding and 63.84 million shares in the current float. Compared to the average trading volume of 1.11M shares, CRBP reached a trading volume of 1896037 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Corbus Pharmaceuticals Holdings Inc. [CRBP]:
BTIG Research have made an estimate for Corbus Pharmaceuticals Holdings Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 17, 2020. While these analysts kept the previous recommendation, Nomura raised their target price to Buy. The new note on the price target was released on March 26, 2020, representing the official price target for Corbus Pharmaceuticals Holdings Inc. stock.
The Average True Range (ATR) for Corbus Pharmaceuticals Holdings Inc. is set at 0.52, with the Price to Sales ratio for CRBP stock in the period of the last 12 months amounting to 15.27. The Price to Book ratio for the last quarter was 23.70, with the Price to Cash per share for the same quarter was set at 0.66.
CRBP stock trade performance evaluation
Corbus Pharmaceuticals Holdings Inc. [CRBP] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.98. With this latest performance, CRBP shares gained by 10.61% in over the last four-week period, additionally plugging by 51.84% over the last 6 months – not to mention a rise of 11.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRBP stock in for the last two-week period is set at 63.28, with the RSI for the last a single of trading hit 65.79, and the three-weeks RSI is set at 61.55 for Corbus Pharmaceuticals Holdings Inc. [CRBP]. The present Moving Average for the last 50 days of trading for this stock 6.66, while it was recorded at 7.23 for the last single week of trading, and 5.62 for the last 200 days.
Corbus Pharmaceuticals Holdings Inc. [CRBP]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Corbus Pharmaceuticals Holdings Inc. [CRBP] shares currently have an operating margin of -226.01. Corbus Pharmaceuticals Holdings Inc.’s Net Margin is presently recorded at -197.69.
Return on Total Capital for CRBP is now -375.38, given the latest momentum, and Return on Invested Capital for the company is -342.06. Return on Equity for this stock declined to -424.29, with Return on Assets sitting at -148.66. When it comes to the capital structure of this company, Corbus Pharmaceuticals Holdings Inc. [CRBP] has a Total Debt to Total Equity ratio set at 153.40. Additionally, CRBP Total Debt to Total Capital is recorded at 60.54, with Total Debt to Total Assets ending up at 19.22. Long-Term Debt to Equity for the company is recorded at 131.50, with the Long-Term Debt to Total Capital now at 51.89.
Reflecting on the efficiency of the workforce at the company, Corbus Pharmaceuticals Holdings Inc. [CRBP] managed to generate an average of -$506,764 per employee. Receivables Turnover for the company is 26.96 with a Total Asset Turnover recorded at a value of 0.75.Corbus Pharmaceuticals Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.60 and a Current Ratio set at 1.60.
Earnings per share (EPS) analysis for Corbus Pharmaceuticals Holdings Inc. [CRBP] stock
With the latest financial reports released by the company, Corbus Pharmaceuticals Holdings Inc. posted 0.03/share EPS, while the average EPS was predicted by analysts to be reported at -0.36/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 108.30%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRBP.
Corbus Pharmaceuticals Holdings Inc. [CRBP]: Insider Ownership positions
There are presently around $268 million, or 50.70% of CRBP stock, in the hands of institutional investors. The top three institutional holders of CRBP stocks are: BLACKROCK INC. with ownership of 5,772,447, which is approximately 6.656% of the company’s market cap and around 0.50% of the total institutional ownership; KNOLL CAPITAL MANAGEMENT, LP, holding 5,045,870 shares of the stock with an approximate value of $38.25 million in CRBP stocks shares; and ETF MANAGERS GROUP, LLC, currently with $27.05 million in CRBP stock with ownership of nearly -38.26% of the company’s market capitalization.
Positions in Corbus Pharmaceuticals Holdings Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 69 institutional holders increased their position in Corbus Pharmaceuticals Holdings Inc. [NASDAQ:CRBP] by around 7,540,423 shares. Additionally, 36 investors decreased positions by around 3,023,217 shares, while 24 investors held positions by with 24,772,814 shares. The mentioned changes placed institutional holdings at 35,336,454 shares, according to the latest SEC report filing. CRBP stock had 25 new institutional investments in for a total of 2,959,991 shares, while 17 institutional investors sold positions of 447,120 shares during the same period.